{
    "ticker": "QNCX",
    "name": "Quince Therapeutics, Inc.",
    "description": "Quince Therapeutics, Inc. is a biotechnology company focused on advancing innovative therapies for patients suffering from neurodegenerative diseases and other serious medical conditions. Founded in 2020, Quince is dedicated to leveraging its proprietary technology platform to develop novel treatments that target unmet medical needs. The company's lead product candidate is in the pipeline to treat conditions such as Alzheimer's disease and other forms of dementia, where it aims to modify disease progression rather than simply addressing symptoms. Quince's research is driven by a deep understanding of disease mechanisms and a commitment to scientific excellence, partnering with leading academic institutions and research organizations to fuel discovery and development. With a robust pipeline of therapeutic candidates, Quince Therapeutics is positioned to make a significant impact on the lives of patients and their families, while also contributing to the broader scientific community. The company\u2019s mission is to enhance patient outcomes through transformative therapies and to foster a culture of innovation and collaboration.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "San Francisco, California, USA",
    "founded": "2020",
    "website": "https://www.quincetherapeutics.com",
    "ceo": "Dr. Jane Doe",
    "social_media": {
        "twitter": "https://twitter.com/QuinceThera",
        "linkedin": "https://www.linkedin.com/company/quince-therapeutics"
    },
    "investor_relations": "https://ir.quincetherapeutics.com",
    "key_executives": [
        {
            "name": "Dr. Jane Doe",
            "position": "CEO"
        },
        {
            "name": "John Smith",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Therapeutic Candidates",
            "products": [
                "QTX-001",
                "QTX-002"
            ]
        }
    ],
    "seo": {
        "meta_title": "Quince Therapeutics, Inc. | Innovative Therapies for Neurodegenerative Diseases",
        "meta_description": "Explore Quince Therapeutics, Inc., a biotechnology company focused on developing innovative therapies for neurodegenerative diseases. Learn about our mission, research, and product pipeline.",
        "keywords": [
            "Quince Therapeutics",
            "Biotechnology",
            "Neurodegenerative Diseases",
            "Alzheimer's Disease",
            "Innovative Therapies"
        ]
    },
    "faq": [
        {
            "question": "What is Quince Therapeutics known for?",
            "answer": "Quince Therapeutics is known for developing innovative therapies for neurodegenerative diseases, particularly Alzheimer's disease."
        },
        {
            "question": "Who is the CEO of Quince Therapeutics?",
            "answer": "Dr. Jane Doe is the CEO of Quince Therapeutics, Inc."
        },
        {
            "question": "Where is Quince Therapeutics headquartered?",
            "answer": "Quince Therapeutics is headquartered in San Francisco, California, USA."
        },
        {
            "question": "What are Quince Therapeutics' main products?",
            "answer": "Quince Therapeutics' main products include therapeutic candidates such as QTX-001 and QTX-002."
        },
        {
            "question": "When was Quince Therapeutics founded?",
            "answer": "Quince Therapeutics was founded in 2020."
        }
    ],
    "competitors": [
        "BIIB",
        "ADBE",
        "SNY"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "VRTX",
        "REGN"
    ]
}